메뉴 건너뛰기




Volumn 95, Issue 8, 2003, Pages 605-610

Randomized double-blind placebo-controlled trial of bestatin in patients with resected state I squamous-cell lung carcinoma

(38)  Ichinose, Yukito a   Genka, Keiichiro b   Koike, Teruaki c   Kato, Harubumi d   Watanabe, Yoh e   Mori, Takashi f   Iioka, Sogo g   Sakuma, Akira h   Ohta, Mitsuo a   Kawamura, M i   Yokoi, K j   Sakuma, T k   Tsubota, N l   Yoshimura, M l   Yanai, N m   Nagasaka, F n   Nakagawa, K o   Tojo, T p   Sato, T q   Ohta, S r   more..


Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ASPARTATE AMINOTRANSFERASE; BESTATIN; CREATININE; ENZYME INHIBITOR; PLACEBO;

EID: 0038364080     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.8.605     Document Type: Article
Times cited : (111)

References (43)
  • 1
    • 0017236348 scopus 로고
    • Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes
    • Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot 1976;29:97-9.
    • (1976) J. Antibiot. , vol.29 , pp. 97-99
    • Umezawa, H.1    Aoyagi, T.2    Suda, H.3    Hamada, M.4    Takeuchi, T.5
  • 3
    • 0020577840 scopus 로고
    • Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin
    • Leyhausen G, Schuster DK, Vaith P, Zahn RK, Umezawa H, Falke D, et al. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin. Biochem Pharmacol 1983;32:1051-7.
    • (1983) Biochem. Pharmacol. , vol.32 , pp. 1051-1057
    • Leyhausen, G.1    Schuster, D.K.2    Vaith, P.3    Zahn, R.K.4    Umezawa, H.5    Falke, D.6
  • 4
    • 0019950846 scopus 로고
    • Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells
    • Müller WE, Schuster DK, Zahn RK, Maidhof A, Leyhausen G, Falke D, et al. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells. Int J Immunopharmacol 1982; 4:393-400.
    • (1982) Int. J. Immunopharmacol. , vol.4 , pp. 393-400
    • Müller, W.E.1    Schuster, D.K.2    Zahn, R.K.3    Maidhof, A.4    Leyhausen, G.5    Falke, D.6
  • 5
    • 0024518875 scopus 로고
    • Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N
    • Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989;83:1299-307.
    • (1989) J. Clin. Invest. , vol.83 , pp. 1299-1307
    • Look, A.T.1    Ashmun, R.A.2    Shapiro, L.H.3    Peiper, S.C.4
  • 6
    • 0025019614 scopus 로고
    • Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells
    • Ashmun RA, Look AT. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 1990;75:462-9.
    • (1990) Blood , vol.75 , pp. 462-469
    • Ashmun, R.A.1    Look, A.T.2
  • 7
    • 0027479013 scopus 로고
    • Aminopeptidase: Structure and function
    • Taylar A. Aminopeptidase: structure and function. FASEB J 1993;7:290-8.
    • (1993) FASEB J. , vol.7 , pp. 290-298
    • Taylar, A.1
  • 8
    • 0027244148 scopus 로고
    • Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!
    • Shipp MA, Look AT. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood 1993;82:1052-70.
    • (1993) Blood , vol.82 , pp. 1052-1070
    • Shipp, M.A.1    Look, A.T.2
  • 9
    • 0027103632 scopus 로고
    • The significance of aminopeptidase and haematopoietic cell differentiation
    • Razak K, Newland AC. The significance of aminopeptidase and haematopoietic cell differentiation. Blood Rev 1992;6:243-50.
    • (1992) Blood Rev. , vol.6 , pp. 243-250
    • Razak, K.1    Newland, A.C.2
  • 10
    • 0025770253 scopus 로고
    • Leucine aminopeptidase: Bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis
    • Burley SK, David PR, Lipscomb WN. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis. Proc Natl Acad Sci U S A 1991;88:6916-20.
    • (1991) Proc. Natl. Acad. Sci. U. S. A. , vol.88 , pp. 6916-6920
    • Burley, S.K.1    David, P.R.2    Lipscomb, W.N.3
  • 11
    • 0033082368 scopus 로고    scopus 로고
    • CD13 - Not just a marker in leukemia typing
    • Riemann D, Kehlen A, Langner J. CD13--not just a marker in leukemia typing. Immunol Today 1999;20:83-8.
    • (1999) Immunol. Today , vol.20 , pp. 83-88
    • Riemann, D.1    Kehlen, A.2    Langner, J.3
  • 12
    • 0027195127 scopus 로고
    • Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation
    • Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993;54:137-43.
    • (1993) Int. J. Cancer , vol.54 , pp. 137-143
    • Saiki, I.1    Fujii, H.2    Yoneda, J.3    Abe, F.4    Nakajima, M.5    Tsuruo, T.6
  • 13
    • 0030048006 scopus 로고    scopus 로고
    • Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitor
    • Fujii H, Nakajima M, Aoyagi T, Tsuruo T. Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitor. Biol Pharm Bull 1996; 19:6-10.
    • (1996) Biol. Pharm. Bull. , vol.19 , pp. 6-10
    • Fujii, H.1    Nakajima, M.2    Aoyagi, T.3    Tsuruo, T.4
  • 14
    • 0033950895 scopus 로고    scopus 로고
    • Aminopeptidase is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
    • Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, et al. Aminopeptidase is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000;60:722-7.
    • (2000) Cancer Res. , vol.60 , pp. 722-727
    • Pasqualini, R.1    Koivunen, E.2    Kain, R.3    Lahdenranta, J.4    Sakamoto, M.5    Stryhn, A.6
  • 15
    • 0035254206 scopus 로고    scopus 로고
    • CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
    • Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro LH. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 2001;97:652-9.
    • (2001) Blood , vol.97 , pp. 652-659
    • Bhagwat, S.V.1    Lahdenranta, J.2    Giordano, R.3    Arap, W.4    Pasqualini, R.5    Shapiro, L.H.6
  • 16
    • 0029781804 scopus 로고    scopus 로고
    • Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines
    • Ezawa K, Minota K, Dobashi K. Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines. Biomed Pharmacother 1996;50:283-9.
    • (1996) Biomed. Pharmacother , vol.50 , pp. 283-289
    • Ezawa, K.1    Minota, K.2    Dobashi, K.3
  • 17
    • 0036161112 scopus 로고    scopus 로고
    • Aminopeptidase N is involved in cell motility and angiogenesis: Its clinical significance in human colon cancer
    • Hashida H, Takabayashi A, Kanai M, Adachi M, Kondo K, Kohno N, et al. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology 2002;122:376-86.
    • (2002) Gastroenterology , vol.122 , pp. 376-386
    • Hashida, H.1    Takabayashi, A.2    Kanai, M.3    Adachi, M.4    Kondo, K.5    Kohno, N.6
  • 20
    • 0029563918 scopus 로고
    • Aminopeptidase inhibitor ubenimex inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity
    • Ino K, Goto S, Nomura S, Isobe K, Nawa A, Okamoto T, et al. Aminopeptidase inhibitor ubenimex inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity. Anticancer Res 1995; 15:2081-7.
    • (1995) Anticancer Res. , vol.15 , pp. 2081-2087
    • Ino, K.1    Goto, S.2    Nomura, S.3    Isobe, K.4    Nawa, A.5    Okamoto, T.6
  • 22
    • 0027321230 scopus 로고
    • Ubenimex in the treatment of acute nonlymphocytic leukemia in adults
    • Urabe A, Mutoh Y, Mizoguchi H, Takaku F, Ogawa N. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults. Ann Hematol 1993; 67:63-6.
    • (1993) Ann. Hematol. , vol.67 , pp. 63-66
    • Urabe, A.1    Mutoh, Y.2    Mizoguchi, H.3    Takaku, F.4    Ogawa, N.5
  • 23
    • 0030451274 scopus 로고    scopus 로고
    • Monocyte activation by an oral immunomodulator bestatin in lymhoma patients following autologous bone marrow transplantation
    • Ino K, Bierman PJ, Varney ML, Heimann DG, Kuszynski CA, Walker SA, et al. Monocyte activation by an oral immunomodulator bestatin in lymhoma patients following autologous bone marrow transplantation. Cancer Immunol Immunother 1996;43:206-12.
    • (1996) Cancer Immunol. Immunother , vol.43 , pp. 206-212
    • Ino, K.1    Bierman, P.J.2    Varney, M.L.3    Heimann, D.G.4    Kuszynski, C.A.5    Walker, S.A.6
  • 25
    • 0022628932 scopus 로고
    • A new international staging system for lung cancer
    • Mountain CF. A new international staging system for lung cancer. Chest 1986;89(4 Suppl):225S-233S.
    • (1986) Chest , vol.89 , Issue.4 SUPPL.
    • Mountain, C.F.1
  • 27
    • 0003486931 scopus 로고
    • Geneva (Switzerland): World Health Organization Offset Publication No. 48
    • WHO handbook for reporting results of cancer treatment. Geneva (Switzerland): World Health Organization Offset Publication No. 48. 1979:14-21.
    • (1979) WHO Handbook for Reporting Results of Cancer Treatment , pp. 14-21
  • 28
    • 0019362251 scopus 로고
    • Introduction to sample size determination and power analysis for clinical trial
    • Lachin JM. Introduction to sample size determination and power analysis for clinical trial. Control Clin Trials 1981;2:93-113.
    • (1981) Control Clin. Trials , vol.2 , pp. 93-113
    • Lachin, J.M.1
  • 29
    • 0000336139 scopus 로고
    • Regression models and life-tables
    • Cox DR. Regression models and life-tables. J Roy Statist Soc Ser B 1972; 34:187-220.
    • (1972) J. Roy Statist. Soc. Ser. B , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 31
    • 0021749274 scopus 로고
    • Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset N0) non-oat cell lung cancer
    • Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg 1984;88:659-62.
    • (1984) J. Thorac. Cardiovasc. Surg. , vol.88 , pp. 659-662
    • Tartter, P.I.1    Burrows, L.2    Kirschner, P.3
  • 32
    • 0027949292 scopus 로고
    • A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung
    • Gail MH. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. Chest 1994;106:287S-92S.
    • (1994) Chest , vol.106
    • Gail, M.H.1
  • 33
    • 0017287037 scopus 로고
    • Regional immunotherapy of lung cancer with intrapleural BCG
    • McKneally MF, Maver CM, Kausel HW. Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1976;1:377-9.
    • (1976) Lancet , vol.1 , pp. 377-379
    • McKneally, M.F.1    Maver, C.M.2    Kausel, H.W.3
  • 34
    • 0027301691 scopus 로고
    • Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer?
    • Ichinose Y, Hara N, Ohta M, Yano T, Maeda K, Asoh H, et al. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? J Thorac Cardiovasc Surg 1993;106: 90-4.
    • (1993) J. Thorac. Cardiovasc. Surg. , vol.106 , pp. 90-94
    • Ichinose, Y.1    Hara, N.2    Ohta, M.3    Yano, T.4    Maeda, K.5    Asoh, H.6
  • 36
    • 0033570968 scopus 로고    scopus 로고
    • Conventional clinicopathologic prognoses factors in surgically resected nonsmall cell lung carcinoma
    • Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Yokose T, et al. Conventional clinicopathologic prognoses factors in surgically resected nonsmall cell lung carcinoma. Cancer 1999;86:1976-84.
    • (1999) Cancer , vol.86 , pp. 1976-1984
    • Suzuki, K.1    Nagai, K.2    Yoshida, J.3    Nishimura, M.4    Takahashi, K.5    Yokose, T.6
  • 37
    • 0025264310 scopus 로고
    • Cancer recurrence after resection: T1 N0 non-small cell lung cancer
    • Thomas P, Rubinstein LV. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Ann Thorac Surg 1990;49:242-7.
    • (1990) Ann. Thorac. Surg. , vol.49 , pp. 242-247
    • Thomas, P.1    Rubinstein, L.V.2
  • 39
    • 0033046028 scopus 로고    scopus 로고
    • Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines
    • Sekine K, Fujii H, Abe F. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines. Leukemia 1999;13:729-34.
    • (1999) Leukemia , vol.13 , pp. 729-734
    • Sekine, K.1    Fujii, H.2    Abe, F.3
  • 40
    • 0033961824 scopus 로고    scopus 로고
    • Modification of the amino terminus of a class II epitope confers degradation by CD13 on dendritic cells and enhances presentation to T cells
    • Dong X, An B, Salvucci Kierstead L, Storkus WJ, Amoscato AA, Salter RD. Modification of the amino terminus of a class II epitope confers degradation by CD13 on dendritic cells and enhances presentation to T cells. J Immunol 2000;164:129-35.
    • (2000) J. Immunol. , vol.164 , pp. 129-135
    • Dong, X.1    An, B.2    Salvucci Kierstead, L.3    Storkus, W.J.4    Amoscato, A.A.5    Salter, R.D.6
  • 41
    • 0035906224 scopus 로고    scopus 로고
    • Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
    • Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001;93:605-18.
    • (2001) J. Natl. Cancer Inst. , vol.93 , pp. 605-618
    • Lippman, S.M.1    Lee, J.J.2    Karp, D.D.3    Vokes, E.E.4    Benner, S.E.5    Goodman, G.E.6
  • 42
    • 0018598923 scopus 로고
    • Restoration of impaired immune function of aged animals by chronic bestatin treatment
    • Bruley-Rosset M, Florentin I, Kiger N, Schulz J, Mathé G. Restoration of impaired immune function of aged animals by chronic bestatin treatment. Immunology 1979;38:75-83.
    • (1979) Immunology , vol.38 , pp. 75-83
    • Bruley-Rosset, M.1    Florentin, I.2    Kiger, N.3    Schulz, J.4    Mathé, G.5
  • 43
    • 0022547774 scopus 로고
    • The effect of ubenimex of N-methyl-N′-nitro-N-nitrosoguanidine-induced stomach tumor in rats
    • Ebihara K, Abe F, Yamashita T, Shibuya K, Hayashi E, Takahashi K, et al. The effect of ubenimex of N-methyl-N′-nitro-N-nitrosoguanidine-induced stomach tumor in rats. J Antibiot (Tokyo) 1986;39:966-70.
    • (1986) J. Antibiot. (Tokyo) , vol.39 , pp. 966-970
    • Ebihara, K.1    Abe, F.2    Yamashita, T.3    Shibuya, K.4    Hayashi, E.5    Takahashi, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.